Education
About Us
Working with TipRanks
Follow Us
David Jin Insider Profile
11 Followers
David Jin, CFO at Fortress Biotech, holds 286.00 shares in Mustang Bio (Ticker: MBIO), holds 1.25M shares in Fortress Biotech (Ticker: FBIO), holds 65.00K shares in Avenue Therapeutics (Ticker: ATXI). Most recently, David Jin Bought ― shares of Mustang Bio on Dec 30, 2025 for an estimated value of $237.12.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Jin holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Jin
David Jin's Trading History
Fortress Biotech
Oct 02, 2025
CFO
Uninformative Buy
3.52K
$5.33M
Avenue Therapeutics
Sep 25, 2024
Interim PFO and COO
Uninformative Buy
―
$48.75K
Mustang Bio
Dec 30, 2025
Director
Informative Buy
237.12
$323.18
List of latest transactions for each holding click on a transaction to see David Jin's performance on stock
You May Also Like
David Jin insider profile FAQ
What is the percentage of profitable transactions made by David Jin?
The percentage of profitable transactions made by David Jin is 33%.
What is the average return per transaction made by David Jin?
The average return per transaction made by David Jin is -23.60%.
What stocks does David Jin hold?
David Jin holds: FBIO, ATXI, MBIO stocks.
What was David Jin’s latest transaction?
David Jin latest transaction was an Informative Buy of $237.12.
What was David Jin's most profitable transaction?
David Jin’s most profitable transaction was an Informative Buy of MBIO stock on December 30, 2025. The return on the trade was 12.60%.
What is David Jin's role in Fortress Biotech?
David Jin's role in Fortress Biotech is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.